Actuate Therapeutics, Inc. Common stock
Actuate Therapeutics, Inc. Common stock scores highest on Torque (88) and lowest on Price (5). Its PosiPenta is 39.84 out of 100, weaker than most similar companies.
On the Penta Grid this week, Actuate Therapeutics, Inc. Common stock is Grid #546 of 837 in the Healthcare sector in United States, and Grid #2,902 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Actuate Therapeutics, Inc. Common stock | 39.84 | 5 | 45 | 16 | 88 | 45 |
| Sintx Technologies, Inc. | 35.31 | 23 | 42 | 37 | 19 | 55 |
| Karyopharm Therapeutics Inc. | 36.57 | 0 | 38 | 10 | 95 | 39 |
| Vyome Holdings, Inc. | 55.52 | 73 | 86 | 25 | 42 | 52 |
| Lipocine Inc. | 40.87 | 44 | 39 | 14 | 58 | 49 |
| Daré Bioscience, Inc. | 27.26 | 0 | 53 | 18 | 19 | 46 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.70 |
| P/B ratio | 14.69 |
EEarnings
| Trailing EPS | ₹-82.40 |
| Forward EPS | ₹-62.83 |
NNitro
| Price | 57.30 |
| 52-week high | 758.67 |
| 52-week low | 38.83 |
| Fall from 52-week high | 92.4% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 1.20 |
| Market cap | ₹137 Cr |
| Insider holding | 15.41% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Actuate Therapeutics, Inc. Common stock's PosiPenta score?
Actuate Therapeutics, Inc. Common stock's PosiPenta is 39.84 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Actuate Therapeutics, Inc. Common stock stand on the Penta Grid?
On the Penta Grid this week, Actuate Therapeutics, Inc. Common stock is Grid #546 of 837 in the Healthcare sector in United States, and Grid #2,902 of 4,000 in United States.
Which PosiPenta pillar is strongest for Actuate Therapeutics, Inc. Common stock?
Torque (durability), with a score of 88 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Actuate Therapeutics, Inc. Common stock?
Price (valuation), with a score of 5 out of 100: much weaker than most similar companies.
Has Actuate Therapeutics, Inc. Common stock's PosiPenta changed since last week?
Yes, it rose 2.94 points, from 36.90 to 39.84.
PositoAI is for research and education only and is not investment advice.